期刊文献+

6-磷酸葡萄糖异构酶抗原在类风湿性关节炎中的表达及初步研究 被引量:9

The study and expression of glucose-6-phosphate isomerase in patients with rheumatoid arthritis
下载PDF
导出
摘要 目的检测6-磷酸葡萄糖异构酶(GPI)抗原在类风湿关节炎(RA)中的表达情况,探讨其在RA中的诊断价值及临床意义。方法用ELISA法测定116例RA患者5、0例疑似RA患者、114例非RA患者及60例健康人血清中的GPI抗原。比较活动性RA患者与非活动性RA患者的GPI抗原水平。分析GPI抗原水平与类风湿因子(RF)的相关性。结果GPI抗原对RA诊断的敏感性为84.5%,特异性为96.6%;GPI抗原与类风湿因子存在相关性,两者联合检测敏感性增加至90.5%;活动性RA患者与非活动性RA患者GPI抗原水平有显著性差异(P<0.01);不同的X线分期GPI抗原水平有显著性差异(P<0.01)。结论GPI抗原对RA的诊断具有良好的敏感性和特异性,并与RA的活动性及病程进展相关,有助于RA诊断及病情的判断。 Objective To examine the expression of glucose-6-phosphate isomerase (GPI) in patients with rheumatoid arthritis (RA), and explore its diagnostic value. Methods The GPI was detected by ELISA in 116 cases of RA, 50 cases of suspected patients from RA, 114 non-RA and 60 cases of normal control. The level of GPI between the active and inactive RA patients was compared, and the correlations among the level of GPI and RF vcere analyzed.Results In RA,its sensitivity was 84.5%, speeifieity was 96.6%. GPI was correlated with rheumatoid factor ( RF). The level of GPI in active RA group was significantly higher than in inactive RA group. The concentration of GPI was significantly different in the patients with different X-ray grades. Conclusion GPI has a reasonable sensitivity and high specificity to diagnosis of RA. GPI positive patients seem to have a more advanced disease process, and GP1 is associated with activity of RA.
出处 《中国实验诊断学》 北大核心 2009年第9期1215-1217,共3页 Chinese Journal of Laboratory Diagnosis
关键词 6-磷酸葡萄糖异构酶 类风湿性关节炎 类风湿因子 glucose-6-phosphateisomerase rhematoid arthritis rheumatoid factor
  • 相关文献

参考文献6

  • 1Schubert D, MaierB, Morawietz L, et al. Immunization with glueese-6- phosphate isomerase induces T cell dependent peripheral polyarthritis in genetically unaltered mice[ J]. J Immunol, 2004,172(7) : 4503.
  • 2Schaller M, Burton DR, Ditzel HJ. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal mode and human disease[J]. Nat Immunol,2001,2:746.
  • 3Kim Jy, Lee MH, Jung KI, et al. Detection of anitibodies against glucose 6-phosphate isomerase in synovial fluid of rhemnatoid arthritis using surface plasman resonance[ J ]. Exp Mol Med, 2003,35 : 310.
  • 4Herve CA, Wait R, Venables PJ. Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis [ J ]. Rheumatoiogy (Oxford), 2003,42: 986.
  • 5王晓霞,李小峰,王来远,胡学芳,张琳,李雪飞.类风湿关节炎血清基质金属蛋白酶-3水平及其影响因素的探讨[J].中华风湿病学杂志,2004,8(1):16-19. 被引量:32
  • 6Yu FL,Liao MH,Lee JW,et al.Induction of hepatoma cells migration by phosphate glucose isomerase autocrine motility factor through the up regulation of matrix metalloproteinase-3 [ J ]. Biochem Biophys Res Commun, 2004,314:76.

二级参考文献16

  • 1Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 2Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 3Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 4Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 5Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 6Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 7Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 8Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.
  • 9Zucker S,Hymovitz M,Conner C,et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tis-sues:clinical experimental applications.Ann NY Acad Sci, 1999,878:212-227.
  • 10Okada Y.Proteinases and matrix degradation. In:Kelley WN,Ruddy S,Harris ED,eds.Textbook of rheumatology.6th ed. Philadelphia:WB Saunders,2000.55-72.

共引文献31

同被引文献54

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部